Leadership Team

Home / Governance / Leadership Team

David J. Endicott, Chief Executive Officer


David J. Endicott is the CEO of Alcon, a member of its Board of Directors, and leads the Alcon Executive Committee. He joined Alcon in July of 2016 as Chief Operating Officer. Prior to Alcon, Mr. Endicott was President of Hospira Infusion Systems, a Pfizer company. During his tenure there, he led Hospira’s medical device business through a turnaround, carve-out, and eventual sale. Critical to the turnaround, he advanced the company’s product pipeline, returned its products to market from quality disruptions and accelerated global growth. Before joining Hospira, David served as an officer and executive committee member of Allergan where he spent more than 25 years of his career in leadership roles across Europe, Asia, Latin America and the US. He accelerated Allergan’s international growth and successfully built new markets focused on medical specialties in the areas of ophthalmology, plastic surgery, dermatology and aesthetic medicine. He currently serves on the Board of Directors of AdvaMed, and has previously served on the Boards of Zeltiq (NASDAQ: ZLTQ), and Orexigen (NASDAQ: OREX).

David holds an undergraduate degree in Chemistry from Whitman College, an MBA from the University of Southern California, and is a graduate of the Advanced Management Program at the Harvard Business School.

Laurent Attias, SVP, Head Global Corp Dev Strategy, BD&L, and M&A


Laurent Attias is Senior Vice President, Corporate Development Strategy at Alcon. During his more than 20 years at Alcon, Mr. Attias progressed through the Sales and Marketing organizations by defining key strategic directions for Surgical and Pharmaceutical flagship brands. Starting in 2002, Mr. Attias held the position of Vice President, Refractive Sales and Marketing, where he helped define Alcon’s participation in the Laser Refractive market. Mr. Attias moved to Europe in 2009 to assume the role of Vice President, Central & Eastern Europe, Italy and Greece. In 2010, Mr. Attias was promoted to President, Europe, Middle East & Africa (EURMEA). Previously, Mr. Attias served as Vice President/General Manager of Alcon Canada, an international relocation role he assumed in 2007.

Mr. Attias holds both a Bachelor of Business Administration in Marketing and an MBA from Texas Christian University in Fort Worth.

Heather Attra, SVP, Head Global Quality


Heather Attra is Senior Vice President, Head Global Quality for Alcon. Ms. Attra joined Novartis in 2010 as the Ciba Vision Head of Quality for the Americas. She later served as Ciba Vision’s Vice President of Compliance and Alcon’s Vice President of Quality for both the Vision Care and Surgical franchises. Most recently, Ms. Attra held the position of Global Head of Manufacturing and Technical Operations for Alcon’s Vision Care franchise. Prior to joining Alcon, Ms. Attra has held a variety of quality management positions of increasing responsibility at Catalent Pharma Solutions.

Ms. Attra holds a Bachelor of Science degree in Biomedical Science from Texas A&M in College Station, Texas.

Jeannette Bankes, President & GM, Global Surgical Franchise


Jeannette Bankes is President & General Manager, Global Surgical Franchise for Alcon. Prior to joining Alcon, Ms. Bankes was General Manager, Urology & Pelvic Health for Boston Scientific, where she was responsible for the entire scope of the global business including commercial sales, marketing, R&D, regulatory, operations, manufacturing, supply chain, quality, clinical research, and new business development. During her 15-year tenure at Boston Scientific, Ms. Bankes served as Vice President of Clinical & Regulatory Affairs, Director of Scientific Communications, and Director of Medical Affairs. Ms. Bankes began her career with Merck & Co., where she held diverse roles of increasing responsibility in sales, marketing, clinical and biological manufacturing.

Ms. Bankes holds a Bachelor of Science in Biochemistry & Medical Technology from Kutztown University.

Royce Bedward, SVP, General Counsel & Corporate Secretary


Royce Bedward is Senior Vice President, General Counsel and Corporate Secretary for Alcon. Mr. Bedward joined Alcon in 2016 from Hospira, where he played a key role in the company’s turnaround, overseeing M&A, securities, litigation, regulatory and compliance matters. He joined Hospira in 2004 as Vice President of Litigation and Human Resources and led its spin-off from Abbott Laboratories.

Mr. Bedward holds a Bachelor’s degree in Business Administration from Saint Norbert College, De Pere, Wisconsin, and a Juris Doctor degree from the University of Illinois College of Law, Champaign, Illinois.

Ian Bell, President, International


Ian Bell is President, International at Alcon. Prior to this role, Mr. Bell was the Region President, Europe, Middle East and Africa since 2016. Mr. Bell brings more than 20 years of experience in the medical device and pharmaceutical industry. He joined Alcon from Hospira Inc. where he served as Corporate Vice President and President of the EMEA region. Prior to his work at Hospira Inc., Mr. Bell was Corporate Vice President and President of Allergan’s Asia Pacific region, based in Singapore from 2008 to 2014. Mr. Bell joined Allergan in 2005 as Vice President and Managing Director of its neurosciences division for Europe, Middle East and Africa. Mr. Bell began his career at GlaxoSmithKline where he held roles of increasing responsibility in sales, marketing and strategy for more than 10 years.

Mr. Bell was awarded the degree of Bachelor of Arts with honors in Economics from the University of York in the United Kingdom.

Sergio Duplan, President, North America


Sergio Duplan is President for the United States and Canada at Alcon. He leads the Surgical and Vision Care business units. Mr. Duplan began his career with Novartis in 2004 as Vice President of Pharma Sales in Mexico and was soon promoted to Head of Pharma Marketing and Sales for Latin America. In 2008, he became CPO Head and Country President of Novartis Mexico. Prior to his current role, Mr. Duplan was President for Latin America and Canada at Alcon for three years. He was appointed to his current role in August 2015. Prior to joining Novartis, Mr. Duplan held several positions of increasing responsibility in Sales, Finance and Country Management at Procter & Gamble and Eli Lilly and Company.

Mr. Duplan holds a Bachelor’s in Industrial Engineering from Universidad Iberoamericana, in Mexico City, Mexico and an MBA from The Wharton School at the University of Pennsylvania, in the United States.

Karen King, SVP, Investor Relations & Communications


Karen King is Senior Vice President, Head Global Investor Relations & Communications for Alcon. Prior to joining Alcon, Ms. King was Vice President, Investor Relations and Corporate Communications for LivaNova, a global medical technology company. Previously, Ms. King served as Corporate Vice President, Investor Relations at Hospira, and Vice President Investor Relations at Career Education Corporation.

Ms. King holds a Bachelor of Science degree in Finance from the Indiana University, and completed the Post Baccalaureate Life Sciences program at Loyola University.

Franck Leveiller, SVP, Head Global R&D


Franck Leveiller is Head, Global R&D for Alcon. Mr. Leveiller joined Alcon in June 2011 as VP and Head of R&D Vision Care, and in June 2015 assumed the role of Head, R&D Surgical Franchise at Alcon. Before joining Alcon, Mr. Leveiller was the Global Head of R&D at Ciba Vision, after two years with Novartis Pharmaceuticals as Global Head Technical R&D, Project Management. Prior to Novartis, he held R&D positions with pharmaceutical companies, such as AstraZeneca, Aventis and Rhône-Poulenc Rorer.

Franck has a Ph.D. in Physical Chemistry from the Weizmann Institute of Science, Israel, where he was awarded the John F. Kennedy Memorial prize for outstanding Ph.D. research work.

Sue-Jean Lin, SVP, Chief Information Officer


Sue-Jean Lin is Senior Vice President & Chief Information Officer for Alcon. Ms. Lin joined Alcon in August of 2018. Prior to her current role, Ms. Lin was Senior Vice President and Chief Information Officer for Hill-Rom, a global medical technology company. Prior to joining Hill-Rom in 2016, she was the Senior Vice President and Chief Information Officer for Allergan. Previously, Ms. Lin was the Vice President of Finance & Regional Controller for Allergan for its Europe, Middle East, and Africa and Asia Pacific. In 2015, she also served as Interim Executive for Presbyterian Healthcare Services in the capacity of Senior Vice President and Chief Information Officer.

Ms. Lin holds both a Bachelor’s degree in Accounting and a Master’s degree in Business Administration from the University of Nevada, Reno. She also completed the Executive Leadership Program from the University of Southern California, Marshall School of Business, and holds a Cybersecurity Oversight certificate from Software Engineering Institute of Carnegie Mellon University.

Kim Martin, SVP, Chief Human Resources Officer


Kim Martin is the Senior Vice President and Chief Human Resources Officer for Alcon. Prior to joining Alcon, Ms. Martin was Chief Human Resources Officer for Worldpay, a $4 billion global payment processing and technology provider. She has also served as an executive human resources leader at Zimmer Holdings Inc., as well as more than 11 years in progressive human resources and talent acquisition positions at General Electric Healthcare.

Ms. Martin attended the University of Illinois, Champaign-Urbana, where she received her Bachelor of Arts in Speech Communications and her Masters in Labor and Industrial Relations.

Ed McGough, SVP, Head Global Manufacturing & Technical Operations


Ed McGough is Alcon’s Senior Vice President of Global MTO. Mr. McGough joined Alcon in April 1991 as a Manager of Quality Assurance and Regulatory. Following this role, he held various positions at Alcon, including Director of Quality Assurance and Director of Operations. Mr. McGough has also served as Vice President and General Manager of Fort Worth and Houston manufacturing. Following this role, he served as Vice President, Manufacturing, Pharmaceutical Operations. Prior to joining Alcon, Mr. McGough served in various quality engineering/management roles with Baxter Healthcare Corporation.

Mr. McGough earned a Bachelor of Science in Industrial Engineering from Louisiana Tech University in 1983. He is also a 1999 graduate of the Stanford Executive Program.

Rajkumar Narayanan, SVP, Operational Strategy & Chief Transformation Officer


Rajkumar Narayanan is the Senior Vice President, Operational Strategy & Chief Transformation Officer at Alcon. Mr. Narayanan has over 30 years of experience in the medical device, pharmaceutical and consumer sectors. Prior to joining Alcon, he was Senior Vice President and Region President of Allergan, Asia Pacific. He had an over 20-year history with Allergan as Vice President, Medical Aesthetics for Allergan Europe, Africa and the Middle East. Prior to this he was Vice President, Allergan Greater China and Japan. Mr. Narayanan worked for Unilever in India before joining Allergan in 1995.

He has a Bachelor of Finance and Economics degree from Bombay University in India.

Michael Onuscheck, President, Global Business & Innovation


Michael Onuscheck is President, Global Business & Innovation at Alcon. Previously, Mr. Onuscheck led Alcon’s Surgical business as President & General Manager. Mr. Onuscheck joined Alcon in February 2015 from Boston Scientific. Mr. Onuscheck held the position of President of Boston Scientific EMEA. He previously served as Senior Vice President and President of Boston Scientific’s Neuromodulation Division. Prior to the Boston Scientific's acquisition of Advanced Bionics (BSC Neuromodulation), Mr. Onuscheck held a variety of marketing and sales management positions at Medtronic Sofamor. He also held various sales and management positions for Pfizer.

Mr. Onuscheck earned his degree in Business Administration and Psychology from Washington and Jefferson College in Washington, Pennsylvania.

Andy Pawson, President & GM, Global Vision Care Franchise


Andy Pawson is President & General Manager, Global Vision Care Franchise. Mr. Pawson joined Alcon in January 2018. Prior to joining Alcon, Mr. Pawson was Chief Marketing Officer & Vice President, Global Marketing & Sales, for Kimberly-Clark’s Professional Division. Before moving to the United States, Mr. Pawson was Vice President, Marketing, Brands and Innovation, for Kimberly-Clark’s European Consumer division. During his 25 years at Kimberly-Clark, he progressed his career in several senior roles across Marketing, Strategy, Regional General Management, Sales and Manufacturing. Mr. Pawson began his career with Unilever Frozen Foods, as an operations manager.

Mr. Pawson holds a Bachelor of Science in Mechanical Engineering from University College London in the United Kingdom.

Tim Stonesifer, SVP, Chief Financial Officer


Tim Stonesifer is Senior Vice President and Chief Financial Officer for Alcon. Prior to joining Alcon, Mr. Stonesifer was Executive Vice President and Chief Financial Officer for Hewlett Packard Enterprise. Prior to HP’s separation into two companies—Hewlett Packard Enterprise and HP Inc.—Mr. Stonesifer served as Chief Financial Officer for HP’s Enterprise Group. Previously, Mr. Stonesifer spent three years with General Motors where he served as the Chief Financial Officer of International Operation. He also spent a year as the Chief Financial Officer for Algeco Scottsman. Before his career at General Motors, Mr. Stonesifer worked at General Electric for 18 years. Mr. Stonesifer’s last position at General Electric was as Chief Financial Officer of the company’s Plastics business. While at General Electric, he also held other Finance leadership roles in Insurance, Equipment Leasing, Structured Finance, and Corporate Audit. Mr. Stonesifer started his career in the Financial Management Program at General Electric.

Mr. Stonesifer holds a Bachelor of Arts in Economics from the University of Michigan.